Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a significant clinical ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 4 clinical study ...

If you're looking at Amgen and wondering whether it's time to buy, hold, or maybe even take profits, you're not alone. The ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...

Six years since the FDA blessed Sanofi and Regeneron’s Dupixent as the first biologic to treat chronic rhinosinusitis with ...

Adam Elinoff will become Aglient Technologies' CFO on Nov. 17. (courtesy photo) Agilent Technologies, a supplier of laboratory medical equipment to the biotechnology industry that is based in Santa ...

Amazon's AI push, Wells Fargo's post-cap growth, and Amgen's new drug momentum headline Zacks' latest top analyst reports.

BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric cancer study, improving overall ...

Amgen stock soared as much as 16% on Friday after it reported first-quarter earnings. The company talked up its experimental GLP-1 weight-loss drug, MariTide. The new weight loss drug could be ...

In the current market session, Amgen Inc. (NASDAQ: AMGN) share price is at $295.58, after a 0.08% drop. Over the past month, ...

Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective ...